Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Fulgent Genetics Inc (Symbol: FLGT), where a total volume of 2,687 contracts has been traded thus far today, a contract volume which is representative of approximately 268,700 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 54.1% of FLGT's average daily trading volume over the past month, of 496,980 shares. Particularly high volume was seen for the $70 strike put option expiring February 18, 2022, with 1,767 contracts trading so far today, representing approximately 176,700 underlying shares of FLGT. Below is a chart showing FLGT's trailing twelve month trading history, with the $70 strike highlighted in orange:
CloudFlare Inc (Symbol: NET) options are showing a volume of 33,874 contracts thus far today. That number of contracts represents approximately 3.4 million underlying shares, working out to a sizeable 50.3% of NET's average daily trading volume over the past month, of 6.7 million shares. Particularly high volume was seen for the $95 strike put option expiring February 18, 2022, with 4,625 contracts trading so far today, representing approximately 462,500 underlying shares of NET. Below is a chart showing NET's trailing twelve month trading history, with the $95 strike highlighted in orange:
And Mednax, Inc. (Symbol: MD) saw options trading volume of 2,003 contracts, representing approximately 200,300 underlying shares or approximately 49.9% of MD's average daily trading volume over the past month, of 401,115 shares. Particularly high volume was seen for the $25 strike put option expiring February 18, 2022, with 1,500 contracts trading so far today, representing approximately 150,000 underlying shares of MD. Below is a chart showing MD's trailing twelve month trading history, with the $25 strike highlighted in orange:
For the various different available expirations for FLGT options, NET options, or MD options, visit StockOptionsChannel.com.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
